ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1AAPL | APPLE INC | Technology | $5.16T | 23.26% |
2NVDA | NVIDIA CORP | Technology | $4.01T | 18.06% |
3AMZN | AMAZON COM INC | Consumer Cyclical | $2.89T | 13.04% |
4LLY | ELI LILLY & CO | Healthcare | $1.34T | 6.06% |
5JNJ | JOHNSON & JOHNSON | Healthcare | $682.52B | 3.08% |
6MA | MASTERCARD INC | Financial Services | $568.53B | 2.56% |
7MRK | MERCK & CO INC | Healthcare | $362.27B | 1.63% |
8HD | HOME DEPOT INC | Consumer Cyclical | $347.46B | 1.57% |
9GE | GE AEROSPACE | Industrials | $341.89B | 1.54% |
10MS | MORGAN STANLEY | Financial Services | $295.68B | 1.33% |
11NFLX | NETFLIX INC | Communication Services | $257.43B | 1.16% |
12AMGN | AMGEN INC | Healthcare | $252.64B | 1.14% |
13GEV | GE VERNOVA INC | Utilities | $216.64B | 0.98% |
14GILD | GILEAD SCIENCES INC | Healthcare | $208.31B | 0.94% |
15KLAC | KLA CORP | Technology | $204.96B | 0.92% |
16PFE | PFIZER INC | Healthcare | $164.33B | 0.74% |
17SCHW | SCHWAB CHARLES CORP | Financial Services | $158.31B | 0.71% |
18TJX | TJX COMPANIES INC | Consumer Cyclical | $149.57B | 0.67% |
19SCCO | SOUTHERN COPPER CORP | Basic Materials | $142.03B | 0.64% |
20LMT | LOCKHEED MARTIN CORP | Industrials | $139.55B | 0.63% |
21VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $137.57B | 0.62% |
22SNDK | SANDISK CORP | Technology | $133.39B | 0.60% |
23APP | APPLOVIN CORP | Technology | $130.43B | 0.59% |
24BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $127.39B | 0.57% |
25STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $125.14B | 0.56% |
26REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $98.40B | 0.44% |
27MMM | 3M CO | Industrials | $96.24B | 0.43% |
28FTNT | FORTINET INC | Technology | $95.17B | 0.43% |
29UPS | UNITED PARCEL SERVICE INC | Industrials | $93.99B | 0.42% |
30ADBE | ADOBE INC | Technology | $92.84B | 0.42% |
31EMR | EMERSON ELECTRIC CO | Industrials | $91.57B | 0.41% |
32BX | BLACKSTONE INC | Financial Services | $89.04B | 0.40% |
33AMT | AMERICAN TOWER CORP | Real Estate | $88.02B | 0.40% |
34MSI | MOTOROLA SOLUTIONS INC | Technology | $87.69B | 0.40% |
35MCO | MOODYS CORP | Financial Services | $87.33B | 0.39% |
36SHW | SHERWIN WILLIAMS CO | Basic Materials | $84.89B | 0.38% |
37ITW | ILLINOIS TOOL WORKS INC | Industrials | $81.49B | 0.37% |
38CL | COLGATE PALMOLIVE CO | Consumer Defensive | $77.82B | 0.35% |
39SPG | SIMON PROPERTY GROUP INC | Real Estate | $75.33B | 0.34% |
40HOOD | ROBINHOOD MARKETS INC | Financial Services | $73.25B | 0.33% |
41COR | CENCORA INC | Healthcare | $66.67B | 0.30% |
42TRGP | TARGA RESOURCES CORP | Energy | $63.57B | 0.29% |
43LNG | CHENIERE ENERGY INC | Energy | $63.20B | 0.28% |
44BE | BLOOM ENERGY CORP | Industrials | $59.70B | 0.27% |
45AME | AMETEK INC | Industrials | $55.27B | 0.25% |
46IDXX | IDEXX LABORATORIES INC | Healthcare | $54.99B | 0.25% |
47ADSK | AUTODESK INC | Technology | $54.23B | 0.24% |
48TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $50.93B | 0.23% |
49ONC | BEONE MEDICINES LTD | Healthcare | $47.50B | 0.21% |
50VST | VISTRA CORP | Utilities | $45.65B | 0.21% |
51AMP | AMERIPRISE FINANCIAL INC | Financial Services | $44.58B | 0.20% |
52LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.46B | 0.19% |
53KR | KROGER CO | Consumer Defensive | $41.23B | 0.19% |
54TEAM | ATLASSIAN CORP | Technology | $38.35B | 0.17% |
55IBKR | INTERACTIVE BROKERS GROUP INC | Financial Services | $36.85B | 0.17% |
56TKO | TKO GROUP HOLDINGS INC | Communication Services | $36.60B | 0.17% |
57NTAP | NETAPP INC | Technology | $36.55B | 0.16% |
58MTD | METTLER TOLEDO INTERNATIONAL INC | Healthcare | $34.43B | 0.16% |
59ZTS | ZOETIS INC | Healthcare | $33.71B | 0.15% |
60EXPE | EXPEDIA GROUP INC | Consumer Cyclical | $30.95B | 0.14% |
61DXCM | DEXCOM INC | Healthcare | $30.35B | 0.14% |
62ARES | ARES MANAGEMENT CORP | Financial Services | $29.88B | 0.13% |
63CQP | CHENIERE ENERGY PARTNERS LP | Energy | $29.72B | 0.13% |
64WSM | WILLIAMS SONOMA INC | Consumer Cyclical | $29.49B | 0.13% |
65ULTA | ULTA BEAUTY INC | Consumer Cyclical | $27.83B | 0.13% |
66JBL | JABIL INC | Technology | $26.77B | 0.12% |
67DLTR | DOLLAR TREE INC | Consumer Defensive | $26.51B | 0.12% |
68TPR | TAPESTRY INC | Consumer Cyclical | $26.06B | 0.12% |
69INSM | INSMED INC | Healthcare | $25.90B | 0.12% |
70UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 0.11% |
71TROW | PRICE T ROWE GROUP INC | Financial Services | $23.09B | 0.10% |
72THC | TENET HEALTHCARE CORP | Healthcare | $22.83B | 0.10% |
73LPLA | LPL FINANCIAL HOLDINGS INC | Financial Services | $22.76B | 0.10% |
74BBY | BEST BUY CO INC | Consumer Cyclical | $21.69B | 0.10% |
75CDW | CDW CORP | Technology | $21.57B | 0.10% |
76ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $20.98B | 0.09% |
77WWD | WOODWARD INC | Industrials | $19.60B | 0.09% |
78TPL | TEXAS PACIFIC LAND CORP | Energy | $19.39B | 0.09% |
79TSCO | TRACTOR SUPPLY CO | Consumer Cyclical | $19.00B | 0.09% |
80FTAI | FTAI AVIATION LTD | Industrials | $18.70B | 0.08% |
81TPG | TPG INC | Financial Services | $18.52B | 0.08% |
82MEDP | MEDPACE HOLDINGS INC | Healthcare | $18.37B | 0.08% |
83NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 0.08% |
84HAS | HASBRO INC | Consumer Cyclical | $16.99B | 0.08% |
85WMG | WARNER MUSIC GROUP CORP | Communication Services | $16.57B | 0.07% |
86NTNX | NUTANIX INC | Technology | $16.47B | 0.07% |
87LAMR | LAMAR ADVERTISING CO | Real Estate | $16.22B | 0.07% |
88BURL | BURLINGTON STORES INC | Consumer Cyclical | $15.82B | 0.07% |
89JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.43B | 0.07% |
90OWL | BLUE OWL CAPITAL INC | Financial Services | $15.28B | 0.07% |
91CHTR | CHARTER COMMUNICATIONS INC | Communication Services | $15.18B | 0.07% |
92MANH | MANHATTAN ASSOCIATES INC | Technology | $14.89B | 0.07% |
93EHC | ENCOMPASS HEALTH CORP | Healthcare | $13.82B | 0.06% |
94SEIC | SEI INVESTMENTS CO | Financial Services | $12.92B | 0.06% |
95RRX | REGAL REXNORD CORP | Industrials | $12.02B | 0.05% |
96ELS | EQUITY LIFESTYLE PROPERTIES INC | Real Estate | $11.99B | 0.05% |
97RYAN | RYAN SPECIALTY HOLDINGS INC | Financial Services | $11.61B | 0.05% |
98GNRC | GENERAC HOLDINGS INC | Industrials | $11.38B | 0.05% |
99EVR | EVERCORE INC | Financial Services | $11.22B | 0.05% |
100PAYC | PAYCOM SOFTWARE INC | Technology | $11.21B | 0.05% |
101SF | STIFEL FINANCIAL CORP | Financial Services | $10.78B | 0.05% |
102PODD | INSULET CORP | Healthcare | $10.36B | 0.05% |
103LTH | LIFE TIME GROUP HOLDINGS INC | Consumer Cyclical | $10.23B | 0.05% |
104FRHC | FREEDOM HOLDING CORP | Financial Services | $10.08B | 0.05% |
105LFUS | LITTELFUSE INC | Technology | $10.08B | 0.05% |
106HLI | HOULIHAN LOKEY INC | Financial Services | $9.96B | 0.04% |
107MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $9.88B | 0.04% |
108AYI | ACUITY INC (DE) | Industrials | $9.81B | 0.04% |
109TGTX | TG THERAPEUTICS INC | Healthcare | $9.76B | 0.04% |
110MUSA | MURPHY USA INC | Consumer Cyclical | $9.68B | 0.04% |
111DKNG | DRAFTKINGS INC | Consumer Cyclical | $9.53B | 0.04% |
112RHP | RYMAN HOSPITALITY PROPERTIES INC | Real Estate | $9.42B | 0.04% |
113VIRT | VIRTU FINANCIAL INC | Financial Services | $9.26B | 0.04% |
114MORN | MORNINGSTAR INC | Financial Services | $9.13B | 0.04% |
115CHWY | CHEWY INC | Consumer Cyclical | $9.08B | 0.04% |
116PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $8.77B | 0.04% |
117EAT | BRINKER INTERNATIONAL INC | Consumer Cyclical | $8.21B | 0.04% |
118CORT | CORCEPT THERAPEUTICS INC | Healthcare | $8.07B | 0.04% |
119VCTR | VICTORY CAPITAL HOLDINGS INC | Financial Services | $7.69B | 0.03% |
120PACS | PACS GROUP INC | Healthcare | $7.62B | 0.03% |
121AXSM | AXSOME THERAPEUTICS INC | Healthcare | $7.59B | 0.03% |
122KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $7.56B | 0.03% |
123AMRX | AMNEAL PHARMACEUTICALS INC | Healthcare | $7.56B | 0.03% |
124YOU | CLEAR SECURE INC | Technology | $7.46B | 0.03% |
125ANDG | ANDERSEN GROUP INC | Consumer Cyclical | $7.39B | 0.03% |
126CHE | CHEMED CORP | Healthcare | $7.16B | 0.03% |
127SNEX | STONEX GROUP INC | Financial Services | $6.89B | 0.03% |
128CHDN | CHURCHILL DOWNS INC | Consumer Cyclical | $6.83B | 0.03% |
129CVLT | COMMVAULT SYSTEMS INC | Technology | $6.80B | 0.03% |
130FPS | FORGENT POWER SOLUTIONS INC | Industrials | $6.74B | 0.03% |
131ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $6.66B | 0.03% |
132LNTH | LANTHEUS HOLDINGS INC | Healthcare | $6.62B | 0.03% |
133FTDR | FRONTDOOR INC | Consumer Cyclical | $6.45B | 0.03% |
134CTVA | CORTEVA INC | Basic Materials | $6.13B | 0.03% |
135GLXY | GALAXY DIGITAL INC | Financial Services | $5.86B | 0.03% |
136OUT | OUTFRONT MEDIA INC | Real Estate | $5.85B | 0.03% |
137MKTX | MARKETAXESS HOLDINGS INC | Financial Services | $5.81B | 0.03% |
138LB | LANDBRIDGE CORP | Energy | $5.44B | 0.02% |
139CON | CONCENTRA GROUP HOLDINGS PARENT INC | Healthcare | $5.44B | 0.02% |
140MTN | VAIL RESORTS INC | Consumer Cyclical | $5.39B | 0.02% |
141SSRM | SSR MINING INC | Basic Materials | $5.38B | 0.02% |
142CAKE | CHEESECAKE FACTORY INC | Consumer Cyclical | $5.29B | 0.02% |
143CHH | CHOICE HOTELS INTERNATIONAL INC | Consumer Cyclical | $5.26B | 0.02% |
144BGC | BGC GROUP INC | Financial Services | $5.24B | 0.02% |
145HLNE | HAMILTON LANE INC | Financial Services | $5.23B | 0.02% |
146SEZL | SEZZLE INC | Financial Services | $5.23B | 0.02% |
147RRR | RED ROCK RESORTS INC | Consumer Cyclical | $5.19B | 0.02% |
148PAGP | PLAINS GP HOLDINGS LP | Energy | $5.18B | 0.02% |
149POWL | POWELL INDUSTRIES INC | Industrials | $5.17B | 0.02% |
150RITM | RITHM CAPITAL CORP | Financial Services | $5.03B | 0.02% |
151TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $4.95B | 0.02% |
152SITE | SITEONE LANDSCAPE SUPPLY INC | Industrials | $4.86B | 0.02% |
153CNK | CINEMARK HOLDINGS INC | Communication Services | $4.80B | 0.02% |
154GFF | GRIFFON CORP | Industrials | $4.75B | 0.02% |
155FHI | FEDERATED HERMES INC | Financial Services | $4.70B | 0.02% |
156PIPR | PIPER SANDLER COMPANIES | Financial Services | $4.65B | 0.02% |
157HIMS | HIMS & HERS HEALTH INC | Consumer Defensive | $4.63B | 0.02% |
158SKT | TANGER INC | Real Estate | $4.56B | 0.02% |
159IONS | IONIS PHARMACEUTICALS INC | Healthcare | $4.55B | 0.02% |
160ATMU | ATMUS FILTRATION TECHNOLOGIES INC | Industrials | $4.53B | 0.02% |
161LAZ | LAZARD INC | Financial Services | $4.49B | 0.02% |
162NOVT | NOVANTA INC | Technology | $4.44B | 0.02% |
163MC | MOELIS & CO | Financial Services | $4.37B | 0.02% |
164FELE | FRANKLIN ELECTRIC CO INC | Industrials | $4.31B | 0.02% |
165ITGR | INTEGER HOLDINGS CORP | Healthcare | $4.30B | 0.02% |
166AZZ | AZZ INC | Industrials | $4.02B | 0.02% |
167HESM | HESS MIDSTREAM LP | Energy | $3.92B | 0.02% |
168PJT | PJT PARTNERS INC | Financial Services | $3.82B | 0.02% |
169TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $3.79B | 0.02% |
170MSGE | MADISON SQUARE GARDEN ENTERTAINMENT CORP | Consumer Cyclical | $3.74B | 0.02% |
171CNS | COHEN & STEERS INC | Financial Services | $3.67B | 0.02% |
172OGN | ORGANON & CO | Healthcare | $3.65B | 0.02% |
173EXTR | EXTREME NETWORKS INC | Technology | $3.57B | 0.02% |
174ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.48B | 0.02% |
175DAVE | DAVE INC | Technology | $3.42B | 0.02% |
176AAMI | ACADIAN ASSET MANAGEMENT INC | Financial Services | $3.36B | 0.02% |
177NHC | NATIONAL HEALTHCARE CORP | Healthcare | $3.30B | 0.01% |
178WT | WISDOMTREE INC | Financial Services | $3.27B | 0.01% |
179IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.15B | 0.01% |
180ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $3.14B | 0.01% |
181AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.09B | 0.01% |
182APAM | ARTISAN PARTNERS ASSET MANAGEMENT INC | Financial Services | $3.09B | 0.01% |
183OSW | ONESPAWORLD HOLDINGS LTD | Consumer Cyclical | $3.07B | 0.01% |
184CARG | CARGURUS INC | Consumer Cyclical | $3.06B | 0.01% |
185XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $3.04B | 0.01% |
186TNET | TRINET GROUP INC | Industrials | $2.99B | 0.01% |
187ADMA | ADMA BIOLOGICS INC | Healthcare | $2.94B | 0.01% |
188PRCH | PORCH GROUP INC | Technology | $2.83B | 0.01% |
189GCMG | GCM GROSVENOR INC | Financial Services | $2.75B | 0.01% |
190RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $2.72B | 0.01% |
191AVAH | AVEANNA HEALTHCARE HOLDINGS INC | Healthcare | $2.67B | 0.01% |
192RH | RH | Consumer Cyclical | $2.45B | 0.01% |
193BLKB | BLACKBAUD INC | Technology | $2.41B | 0.01% |
194BKE | BUCKLE INC | Consumer Cyclical | $2.26B | 0.01% |
195ASAN | ASANA INC | Technology | $2.21B | 0.01% |
196AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.17B | 0.01% |
197SONO | SONOS INC | Technology | $2.14B | 0.01% |
198CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $2.11B | 0.01% |
199NGVT | INGEVITY CORP | Basic Materials | $2.09B | 0.01% |
200SPB | SPECTRUM BRANDS HOLDINGS INC | Consumer Defensive | $2.03B | 0.01% |
201HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.98B | 0.01% |
202NSP | INSPERITY INC | Industrials | $1.90B | 0.01% |
203ZYME | ZYMEWORKS INC | Healthcare | $1.83B | 0.01% |
204LILA | LIBERTY LATIN AMERICA LTD | Communication Services | $1.81B | 0.01% |
205ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.77B | 0.01% |
206SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.72B | 0.01% |
207NRIX | NURIX THERAPEUTICS INC | Healthcare | $1.70B | 0.01% |
208CBL | CBL & ASSOCIATES PROPERTIES INC | Real Estate | $1.68B | 0.01% |
209ENR | ENERGIZER HOLDINGS INC | Industrials | $1.66B | 0.01% |
210ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.62B | 0.01% |
211IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | $1.57B | 0.01% |
212WEN | WENDY'S CO | Consumer Cyclical | $1.56B | 0.01% |
213GLP | GLOBAL PARTNERS LP | Energy | $1.48B | 0.01% |
214PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.01% |
215CBRL | CRACKER BARREL OLD COUNTRY STORE INC | Consumer Cyclical | $1.45B | 0.01% |
216TWFG | TWFG INC | Financial Services | $1.45B | 0.01% |
217PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.44B | 0.01% |
218ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.01% |
219PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.41B | 0.01% |
220PWP | PERELLA WEINBERG PARTNERS | Financial Services | $1.33B | 0.01% |
221ALX | ALEXANDERS INC | Real Estate | $1.26B | 0.01% |
222DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.23B | 0.01% |
223TNDM | TANDEM DIABETES CARE INC | Healthcare | $1.22B | 0.01% |
224ACEL | ACCEL ENTERTAINMENT INC | Consumer Cyclical | $1.11B | 0.01% |
225YELP | YELP INC | Communication Services | $1.10B | 0.00% |
226RPC | RIDGEPOST CAPITAL INC | Financial Services | $1.04B | 0.00% |
227OPY | OPPENHEIMER HOLDINGS INC | Financial Services | $961M | 0.00% |
228MAX | MEDIAALPHA INC | Communication Services | $877M | 0.00% |
229RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.00% |
230MCS | MARCUS CORP | Communication Services | $846M | 0.00% |
231MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $844M | 0.00% |
232CCSI | CONSENSUS CLOUD SOLUTIONS INC | Technology | $771M | 0.00% |
233WLKP | WESTLAKE CHEMICAL PARTNERS LP | Basic Materials | $764M | 0.00% |
234DSP | VIANT TECHNOLOGY INC | Technology | $760M | 0.00% |
235YEXT | YEXT INC | Technology | $757M | 0.00% |
236BFS | SAUL CENTERS INC | Real Estate | $706M | 0.00% |
237ROOT | ROOT INC | Financial Services | $663M | 0.00% |
238LYTS | LSI INDUSTRIES INC | Technology | $568M | 0.00% |
239UHT | UNIVERSAL HEALTH REALTY INCOME TRUST | Real Estate | $538M | 0.00% |
240STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $454M | 0.00% |
241ARVN | ARVINAS INC | Healthcare | $450M | 0.00% |
242SGU | STAR GROUP LP | Energy | $433M | 0.00% |
243PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $418M | 0.00% |
244NPCE | NEUROPACE INC | Healthcare | $413M | 0.00% |
245NXRT | NEXPOINT RESIDENTIAL TRUST INC | Real Estate | $392M | 0.00% |
246QUAD | QUAD/GRAPHICS INC | Industrials | $384M | 0.00% |
247GTE | GRAN TIERRA ENERGY INC | Energy | $339M | 0.00% |
248RM | REGIONAL MANAGEMENT CORP | Financial Services | $311M | 0.00% |
249NEWT | NEWTEKONE INC | Financial Services | $302M | 0.00% |
250SMTI | SANARA MEDTECH INC | Healthcare | $299M | 0.00% |
251PLAY | DAVE & BUSTER'S ENTERTAINMENT INC | Communication Services | $273M | 0.00% |
252ULBI | ULTRALIFE CORP | Industrials | $263M | 0.00% |
253MSB | MESABI TRUST | Basic Materials | $225M | 0.00% |
254DTIL | PRECISION BIOSCIENCES INC | Healthcare | $225M | 0.00% |
255NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $178M | 0.00% |
256STRW | STRAWBERRY FIELDS REIT INC | Real Estate | $178M | 0.00% |
257EMIS | EMMIS ACQUISITION CORP | Financial Services | $163M | 0.00% |
258CPHC | CANTERBURY PARK HOLDING CORP | Consumer Cyclical | $81M | 0.00% |
259XLO | XILIO THERAPEUTICS INC | Healthcare | $58M | 0.00% |
260OESX | ORION ENERGY SYSTEMS INC | Industrials | $54M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $22.17T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 260 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 17%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 7.6% | 14.0% |
| 3 yearsp.a. | 21.2% | 10.6% |
| 5 yearsp.a. | 10.7% | 7.0% |
| 10 yearsp.a. | 14.7% | 6.1% |
| Since inceptionp.a. | 10.1% | 4.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 6.7% | 11.1% |
| 2025 | 19.6% | 12.8% |
| 2024 | 32.8% | 14.2% |
| 2023 | 22.7% | 0.3% |
| 2022 | -23.0% | -5.5% |
| 2021 | 23.6% | -3.9% |
| 2020 | 25.9% | 11.1% |
| 2019 | 25.6% | 8.5% |
| 2018 | 5.4% | 22.0% |
| 2017 | 17.9% | -6.1% |
| 2016 | 8.5% | -12.7% |
| 2015 | 9.8% | 24.3% |
| 2014 | 15.2% | 21.0% |
| 2013 | 38.1% | 5.4% |
| 2012 | 14.0% | 5.4% |
| 2011 | 5.4% | 3.4% |
| 2010 | 14.7% | -11.4% |
| 2009 | 25.5% | -4.1% |
| 2008 | -24.8% | 44.5% |
| 2007 | 14.6% | 12.2% |
| 2006 | 13.2% | -6.4% |
| 2005 | 6.2% | -11.2% |
| 2004 | 5.4% | -10.4% |
| 2003 | 27.6% | -0.8% |
| 2002 | -32.1% | -16.7% |
| 2001 | -13.6% | 1.1% |
| 2000 | 9.2% | 18.6% |
| 1999 | 30.1% | 8.3% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry Operating Profitability Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Operating Profitability signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 84% toward Growth. +1% unclassified (9 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 260 names now. Hypothetical holdings — descriptive, not P&L.